Ardelyx, Inc. (ARDX) vs Sana Biotechnology, Inc. (SANA)

Ardelyx, Inc. and Sana Biotechnology, Inc. are both Biotechnology companies. Ardelyx, Inc. and Sana Biotechnology, Inc. are of similar size ($904.1M and $859.7M). Sana Biotechnology, Inc. has the higher net margin (0.00% vs −12.4%) and the higher return on invested capital (0.00% vs −18.6%). Across the 14 metrics below, Sana Biotechnology, Inc. leads on 8 and Ardelyx, Inc. on 6.

Valuation

Metric ARDX SANA Biotechnology median
P/E n/m n/m 7.88
P/S 1.88 n/m 11.47
P/B 5.69 5.64 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 1.82 n/m 10.73
Earnings yield (6.55%) (25.76%) (28.84%)
Free cash flow yield (2.11%) (15.36%) (23.03%)

Profitability

Metric ARDX SANA Biotechnology median
Gross margin 94.37% 0.00% 65.16%
Operating margin (7.86%) 0.00% 0.00%
Net margin (12.35%) 0.00% 0.00%
Free cash flow margin (3.97%) 0.00% 0.00%
Return on equity (38.61%) (152.87%) (57.72%)
Return on assets (10.68%) (53.41%) (49.22%)
Return on invested capital (18.62%) 0.00% 0.00%

Growth

Metric ARDX SANA Biotechnology median
Revenue growth (TTM) 16.77% — 5.64%
EPS growth (last fiscal year) (52.94%) 17.24% —
Revenue growth, 5-year CAGR 121.90% — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ARDX SANA Biotechnology median
Debt to equity 1.69 0.00 0.00
Current ratio 3.34 1.38 4.73
Net debt to EBITDA 1.63 0.60 0.96

Dividend

Metric ARDX SANA Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ARDX SANA Biotechnology median
Market cap 859.70m 904.07m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack